Foley & Lardner·HEALTHCARE

Court Dismisses FCA Claims Over Medicare Advantage Marketing Practices

In-house counsel for Medicare Advantage organizations must track this ruling, as it confirms routine patient outreach and plan enrollment marketing activities do not meet the threshold for False Claims Act fraud liability, reducing enforcement risk for standard operations.

A sealed False Claims Act (FCA) case targeting Medicare Advantage marketing practices was recently dismissed, with the court ruling in favor of the defense’s argument that the plaintiff’s attempt to classify routine patient-acquisition and outreach activities as federal and state fraud was legally unsupported. The ruling establishes a key precedent for Medicare Advantage stakeholders, clarifying that standard marketing operations for plan enrollment do not constitute FCA fraud. In-house counsel for Medicare Advantage organizations should review existing marketing and outreach protocols to ensure alignment with the court’s reasoning, and maintain documentation validating the legitimate, non-fraudulent nature of these activities to mitigate future enforcement exposure.

false-claims-actmedicare-advantagehealthcare-marketingfca-enforcement

Stay ahead

Join the digest.

One email when the daily AmLaw 100 briefing ships. No noise, no pitch decks — just the grade 4–5 signal.